CEO Daniel Nadler told CNBC that OpenEvidence is used by 40% of physicians in the U.S. and topped $100 million in annual ...

Kimi has a standard mode and a Thinking mode that offers higher output quality. Additionally, a capability called K2.5 Agent ...

OpenEvidence, an AI platform for doctors, announced Wednesday it has raised $250 million in a Series D funding round that ...

OpenEvidence, an artificial intelligence startup known as “ChatGPT for doctors,” clinched a funding round that doubled its ...

Jan 21 (Reuters) - OpenEvidence, an AI startup whose tools are used by U.S. physicians, has raised $250 million in fresh ...

Thrive Capital and DST Global led the investment. It values OpenEvidence at $12 billion, more than ten times what the company was worth after its first funding round last February. The startup has ...

Daniel Nadler, the 42-year-old CEO and cofounder of OpenEvidence, is now worth $7.6 billion as his AI search tool surges in popularity among U.S. doctors.

Chinese artificial intelligence (AI) startup “Moonshot AI” is expected to achieve a corporate valuation of $4 billion (approximately 5.888 trillion Korean won), The Wall Street Journal (WSJ) reported ...

The five-year-old-startup powers OpenAI’s ChatGPT voice mode and raised a $100 million round led by Index Ventures.